|
||||||
Executive Summary Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, "Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Cancer Anorexia-Cachexia Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Anorexia-Cachexia Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials 28 Prominent Drugs 30 Clinical Trial Profile Snapshots 31 Appendix 89 Abbreviations 89 Definitions 89 Research Methodology 90 Secondary Research 90 About GlobalData 91 Contact Us 91 Disclaimer 91 Source 92 List of Figures Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Cancer Anorexia-Cachexia Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 90 List of Tables Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 6 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Cancer Anorexia-Cachexia Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Cancer Anorexia-Cachexia Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Cancer Anorexia-Cachexia Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Cancer Anorexia-Cachexia Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Cancer Anorexia-Cachexia Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Cancer Anorexia-Cachexia Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 Single User License: Site License: Corporate User License: Helsinn Holding S.A. GTx, Inc. Medpace Holdings, Inc. Novartis AG Tsumura & co. Ohr Pharmaceutical Inc. Merck & Co., Inc. Endo International Plc Ark Therapeutics Limited Aeterna Zentaris Inc. |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |